Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
ZS and Quartic will collaborate to help drive resilience, increase adoption of Industry 4.0 and improve predictive decision-making across manufacturing
The curriculum has been curated for General Physicians working in Clinikk
Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Subscribe To Our Newsletter & Stay Updated